{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:10:35Z","timestamp":1793200235219,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ALF-grant","award":["ALFGBG-716671"],"award-info":[{"award-number":["ALFGBG-716671"]}]},{"name":"ALF-grant","award":["ALFGBG2018-03591"],"award-info":[{"award-number":["ALFGBG2018-03591"]}]},{"name":"Funds of the Sahlgrenska University Hospital"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-00944"],"award-info":[{"award-number":["2017-00944"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The T2-FLAIR mismatch sign is an imaging finding highly suggestive of isocitrate dehydrogenase mutated (<jats:italic>IDH-<\/jats:italic>mut) 1p19q non-codeleted (non-codel) gliomas (astrocytomas). In previous studies, it has shown excellent specificity but limited sensitivity for<jats:italic>IDH<\/jats:italic>-mut astrocytomas. Whether the mismatch sign is a marker of a clinically relevant subtype of<jats:italic>IDH-<\/jats:italic>mut astrocytomas is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included histopathologically verified supratentorial lower-grade gliomas (LGG) WHO grade II-III retrospectively during the period 2010\u20132016. In the period 2017\u20132018, patients with suspected LGG radiologically were prospectively included, and in this cohort other diagnoses than glioma could occur. Clinical, radiological and molecular data were collected. For clinical evaluation we included all patients with<jats:italic>IDH<\/jats:italic>-mut astrocytomas. In the 2010\u20132016 cohort DNA methylation analysis with Infinium MethylationEPIC BeadChip (Illumina) was performed for patients with\u00a0an<jats:italic>IDH<\/jats:italic>-mut astrocytoma\u00a0with available tissue. We aimed to examine the association of the T2-FLAIR\u00a0mismatch sign with clinical factors and outcomes. Additionally, we evaluated the diagnostic reliability of the mismatch sign and its relation to methylation profiles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 215 patients with LGG, 135 had known<jats:italic>IDH-<\/jats:italic>mutation and 1p19q codeletion status. Fifty patients had\u00a0an<jats:italic>IDH<\/jats:italic>-mut astrocytoma and 12 of these (24.0%) showed a mismatch sign. The sensitivity and specificity of the mismatch sign for<jats:italic>IDH<\/jats:italic>-mut detection were 26.4 and 97.6%, respectively. There were no differences between patients with\u00a0an<jats:italic>IDH<\/jats:italic>-mut astrocytoma with or without mismatch sign when grouped according to T2-FLAIR mismatch sign with respect to baseline characteristics, clinical outcomes and methylation profiles. The overall interrater agreement between neuroradiologist and clinical neurosurgeons for the T2-FLAIR mismatch sign was significant when all 215 MRI examination assessed (\u03ba\u2009=\u20090.77,<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001,<jats:italic>N<\/jats:italic>\u2009=\u2009215).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The T2-FLAIR mismatch sign in patients with\u00a0an<jats:italic>IDH<\/jats:italic>-mut astrocytoma is not associated with clinical presentation or outcome. It seems unlikely that the<jats:italic>IDH<\/jats:italic>-mut astrocytomas with mismatch sign represent a specific subentity. Finally, we have validated that the T2-FLAIR mismatch sign is a reliable and specific marker of<jats:italic>IDH<\/jats:italic>-mut astrocytomas.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-020-06951-w","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T10:03:03Z","timestamp":1589968983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-2392","authenticated-orcid":false,"given":"Alba","family":"Corell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ferreyra Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickoleta","family":"Hoefling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Carstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Olsson Bontell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella M.","family":"Bj\u00f6rkman-Burtscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Car\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir Store","family":"Jakola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"issue":"6","key":"6951_CR1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803\u201320.","journal-title":"Acta Neuropathol"},{"issue":"26","key":"6951_CR2","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade Gliomas. N Engl J Med. 2015;372(26):2481\u201398.","journal-title":"N Engl J Med"},{"issue":"1","key":"6951_CR3","doi-asserted-by":"crossref","DOI":"10.3171\/2014.10.FOCUS12367","volume":"38","author":"EB Claus","year":"2015","unstructured":"Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M. Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus. 2015;38(1):E6.","journal-title":"Neurosurg Focus"},{"issue":"2","key":"6951_CR4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11060-017-2570-1","volume":"135","author":"O Etxaniz","year":"2017","unstructured":"Etxaniz O, Carrato C, de Aguirre I, Queralt C, Munoz A, Ramirez JL, Rosell R, Villa S, Diaz R, Estival A, et al. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas. J Neuro-Oncol. 2017;135(2):273\u201384.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"6951_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-013-1107-5","volume":"113","author":"H Sun","year":"2013","unstructured":"Sun H, Yin L, Li S, Han S, Song G, Liu N, Yan C. Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis. J Neuro-Oncol. 2013;113(2):277\u201384.","journal-title":"J Neuro-Oncol"},{"issue":"26","key":"6951_CR6","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, et al. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499\u2013508.","journal-title":"N Engl J Med"},{"issue":"20","key":"6951_CR7","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-17-0560","volume":"23","author":"SH Patel","year":"2017","unstructured":"Patel SH, Poisson LM, Brat DJ, Zhou Y, Cooper L, Snuderl M, Thomas C, Franceschi AM, Griffith B, Flanders AE, et al. T2-FLAIR mismatch, an imaging biomarker for IDH and 1p\/19q status in lower-grade Gliomas: a TCGA\/TCIA project. Clin Cancer Res. 2017;23(20):6078\u201385.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"6951_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00234-018-2148-4","volume":"61","author":"DR Johnson","year":"2019","unstructured":"Johnson DR, Kaufmann TJ, Patel SH, Chi AS, Snuderl M, Jain R. There is an exception to every rule-T2-FLAIR mismatch sign in gliomas. Neuroradiology. 2019;61(2):225\u20137.","journal-title":"Neuroradiology"},{"issue":"7697","key":"6951_CR9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u201374.","journal-title":"Nature"},{"issue":"4","key":"6951_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00401-014-1315-x","volume":"128","author":"B Wiestler","year":"2014","unstructured":"Wiestler B, Capper D, Sill M, Jones DT, Hovestadt V, Sturm D, Koelsche C, Bertoni A, Schweizer L, Korshunov A, et al. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathol. 2014;128(4):561\u201371.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"6951_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jnci\/djq497","volume":"103","author":"BC Christensen","year":"2011","unstructured":"Christensen BC, Smith AA, Zheng S, Koestler DC, Houseman EA, Marsit CJ, Wiemels JL, Nelson HH, Karagas MR, Wrensch MR, et al. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst. 2011;103(2):143\u201353.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"6951_CR12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11060-018-03034-6","volume":"141","author":"TA Juratli","year":"2019","unstructured":"Juratli TA, Tummala SS, Riedl A, Daubner D, Hennig S, Penson T, Zolal A, Thiede C, Schackert G, Krex D, et al. Radiographic assessment of contrast enhancement and T2\/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups. J Neuro-Oncol. 2019;141(2):327\u201335.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"6951_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-018-03030-w","volume":"141","author":"D Delev","year":"2019","unstructured":"Delev D, Heiland DH, Franco P, Reinacher P, Mader I, Staszewski O, Lassmann S, Grau S, Schnell O. Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system. J Neuro-Oncol. 2019;141(1):223\u201333.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"6951_CR14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/neuonc\/nox176","volume":"20","author":"MMJ Wijnenga","year":"2018","unstructured":"Wijnenga MMJ, French PJ, Dubbink HJ, Dinjens WNM, Atmodimedjo PN, Kros JM, Smits M, Gahrmann R, Rutten GJ, Verheul JB, et al. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis. Neuro-oncology. 2018;20(1):103\u201312.","journal-title":"Neuro-oncology"},{"issue":"6","key":"6951_CR15","doi-asserted-by":"crossref","DOI":"10.3171\/2015.9.FOCUS15339","volume":"39","author":"P Ferroli","year":"2015","unstructured":"Ferroli P, Broggi M, Schiavolin S, Acerbi F, Bettamio V, Caldiroli D, Cusin A, La Corte E, Leonardi M, Raggi A, et al. Predicting functional impairment in brain tumor surgery: the big five and the Milan complexity scale. Neurosurg Focus. 2015;39(6):E14.","journal-title":"Neurosurg Focus"},{"issue":"2","key":"6951_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"6951_CR17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/neuonc\/noy048","volume":"20","author":"MPG Broen","year":"2018","unstructured":"Broen MPG, Smits M, Wijnenga MMJ, Dubbink HJ, Anten M, Schijns O, Beckervordersandforth J, Postma AA, van den Bent MJ. The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p\/19q-intact lower-grade glioma: a validation study. Neuro-Oncology. 2018;20(10):1393\u20139.","journal-title":"Neuro-Oncology"},{"issue":"9","key":"6951_CR18","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W","volume":"53","author":"V Mor","year":"1984","unstructured":"Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53(9):2002\u20137.","journal-title":"Cancer"},{"issue":"5","key":"6951_CR19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3171\/JNS\/2008\/109\/11\/0817","volume":"109","author":"EF Chang","year":"2008","unstructured":"Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg. 2008;109(5):817\u201324.","journal-title":"J Neurosurg"},{"issue":"9","key":"6951_CR20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30(9):1323\u201341.","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"6951_CR21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/neuonc\/noz011","volume":"21","author":"A Wenger","year":"2019","unstructured":"Wenger A, Ferreyra Vega S, Kling T, Bontell TO, Jakola AS, Caren H. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification. Neuro-Oncol. 2019;21(5):616\u201327.","journal-title":"Neuro-Oncol"},{"issue":"10","key":"6951_CR22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139.","journal-title":"Bioinformatics"},{"issue":"7","key":"6951_CR23","volume":"41","author":"TJ Triche Jr","year":"2013","unstructured":"Triche TJ Jr, Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA methylation BeadArrays. Nucleic Acids Res. 2013;41(7):e90.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"6951_CR24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ Jr, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33(4):558\u201360.","journal-title":"Bioinformatics"},{"issue":"1","key":"6951_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"8","key":"6951_CR26","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/annonc\/mdx230","volume":"28","author":"A.S. Jakola","year":"2017","unstructured":"Jakola AS, Skjulsvik AJ, Myrmel KS, et al. Surgical resection versus watchful waiting in low-grade gliomas. Ann Oncol. 2017;28(8):1942\u201348.","journal-title":"Annals of Oncology"},{"issue":"3","key":"6951_CR27","first-page":"426","volume":"40","author":"PP Batchala","year":"2019","unstructured":"Batchala PP, Muttikkal TJE, Donahue JH, Patrie JT, Schiff D, Fadul CE, Mrachek EK, Lopes MB, Jain R, Patel SH. Neuroimaging-based classification algorithm for predicting 1p\/19q-Codeletion status in IDH-mutant lower grade Gliomas. AJNR Am J Neuroradiol. 2019;40(3):426\u201332.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"6951_CR28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3174\/ajnr.A5572","volume":"39","author":"A Lasocki","year":"2018","unstructured":"Lasocki A, Gaillard F, Gorelik A, Gonzales M. MRI features can predict 1p\/19q status in intracranial Gliomas. AJNR Am J Neuroradiol. 2018;39(4):687\u201392.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"6951_CR29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/picr.PICR_170_17","volume":"9","author":"P Ranganathan","year":"2018","unstructured":"Ranganathan P, Aggarwal R. Common pitfalls in statistical analysis: understanding the properties of diagnostic tests - part 1. Perspect Clin Res. 2018;9(1):40\u20133.","journal-title":"Perspect Clin Res"},{"key":"6951_CR30","volume":"6","author":"HH Cho","year":"2018","unstructured":"Cho HH, Lee SH, Kim J, Park H. Classification of the glioma grading using radiomics analysis. PeerJ. 2018;6:e5982.","journal-title":"PeerJ"},{"issue":"3","key":"6951_CR31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00701-018-03783-3","volume":"161","author":"C Gui","year":"2019","unstructured":"Gui C, Lau JC, Kosteniuk SE, Lee DH, Megyesi JF. Radiology reporting of low-grade glioma growth underestimates tumor expansion. Acta Neurochir. 2019;161(3):569\u201376.","journal-title":"Acta Neurochir"},{"issue":"3","key":"6951_CR32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00701-019-03816-5","volume":"161","author":"AS Jakola","year":"2019","unstructured":"Jakola AS, Reinertsen I. Radiological evaluation of low-grade glioma: time to embrace quantitative data? Acta Neurochir. 2019;161(3):577\u20138.","journal-title":"Acta Neurochir"},{"issue":"2","key":"6951_CR33","first-page":"844","volume":"30","author":"Min Kyoung Lee","year":"2019","unstructured":"Lee MK, Park JE, Jo Y, Park SY, Kim SJ, Kim HS. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2\/FLAIR mismatch sign. Eur Radiol. 2020;30(2):844\u201354.","journal-title":"European Radiology"},{"issue":"2","key":"6951_CR34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.celrep.2018.03.107","volume":"23","author":"CF de Souza","year":"2018","unstructured":"de Souza CF, Sabedot TS, Malta TM, Stetson L, Morozova O, Sokolov A, Laird PW, Wiznerowicz M, Iavarone A, Snyder J, et al. A distinct DNA methylation shift in a subset of Glioma CpG Island Methylator phenotypes during tumor recurrence. Cell Rep. 2018;23(2):637\u201351.","journal-title":"Cell Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-06951-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T09:14:46Z","timestamp":1696151686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-06951-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6951"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06951-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was approved by the regional ethical committee in the region of V\u00e4stra G\u00f6taland (DNR 1067\u201316 and DNR 363\u201317).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Informed consent waived by the ethical committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"450"}}